CX3CR1 and inflammatory bowel disease: As in inflammatory bowel disease, this model is driven by TNFα and RANK-L-producing CD4+ T cells leading to the development of Cx3cr1+ OCLs (Cenci et al., 2000; Ibáñez et al., 2016; Weitzmann and Pacifici, 2006).